Some of key participating players in nephrology and urology-incontinence devices global market are Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimerly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.

Valley Cottage, NY -- (SBWire) -- 02/05/2019 --Incontinence Devices are used in the treatment of urinary tract and nephrological disorder of patient such as Chronic Kidney Disease (CKD), Kidney Stone, Benign Prostatic Hyperplasia (BPH), End Stage Renal Disease (ESRD) and urinary incontinence of pelvic organ prolapse.

According to WHO, more than 190 million patients are suffering from chronic renal failure and undergo renal dialysis and more than 220 million males suffer from diseases associated with prostate glands such as swelling that results in blockage of the flow of urine through the body. The United States national institute of diabetes and digestive and kidney diseases reported that more than 2 million kidney stone patients are diagnosed every year across the U.S.

Nephrology and Urology Incontinence Devices Market: Drivers and Restraints

Presently, the global market for incontinence devices is primarily driven by the rising prevalence of Chronic Kidney Disease (CKD), Benign Prostatic Hyperplasia (BPH) and End Stage Renal Disease (ESRD) Also, increasing prevalence of diabetes and hypertension, aging population and a shortage of kidney donors for transplant. Growing awareness programmes bout these particular disease and personal hygiene among patients will lead the market in the forecast years.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-774

Also, with the increase in healthcare expenditure and favorable reimbursement in the developed countries the market is expected to have a healthy growth.

Nephrology and Urology Incontinence Devices Market: Segmentation

Nephrology and urology-incontinence devices global market is segmented into following types:

Protective Garments for Incontinence
Adult Diapers
Absorbent Pads
Plastic Pants
Protective Undergarments
Urinary Catheters
Foley Catheters
Intermittent Catheters
External Catheters
Urine Bags
Leg Bags
Bedside Bags

Nephrology and Urology Incontinence Devices Market: Overview

With the rapid technological advancement in healthcare industry, and rising incidence of nephron and urological disorders, increasing prevalence of diabetes and hypertension, and aging population. The market is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Nephrology and Urology Incontinence Devices Market: Region-wise Outlook

Depending on geographic regions, incontinence devices global market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America and Europe is expected to capture the largest market shares followed by Asia Pacific countries where the market is expected to grow due to increase awareness of personal hygiene, increase in disposable income of middle class consumer.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-774

Nephrology and Urology Incontinence Devices Market: Key Players

Some of key participating players in nephrology and urology-incontinence devices global market are Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimerly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.